Reuters logo
4 years ago
BRIEF-Elan says FDA grant fast track status to alzheimers treatment
July 17, 2013 / 1:06 PM / 4 years ago

BRIEF-Elan says FDA grant fast track status to alzheimers treatment

LONDON, July 17 (Reuters) - Elan Corporation PLC : * FDA grant fast track designation to ELND005 for the treatment of

neuropsychiatric symptoms in alzheimer's disease * Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below